Silver Book Fact

Healthcare costs of atrial fibrillation

Atrial fibrillation (AF) is a major economic burden for society with the biggest cost driver being hospitalizations—accounting for 52% of costs. Drugs for AF account for 23% of costs, consultations at 9%, further investigations at 8%, loss of work at 6%, and paramedical procedures at 2%.

Le Heuzey J, Paziaud O, Piot O, Ait S, et al. Cost of Care Distribution in Atrial Fibrillation Patients: The COCAF study. Am Heart J. 2004; 147(1): 121-6. https://pubmed.ncbi.nlm.nih.gov/14691429/

Reference

Title
Cost of Care Distribution in Atrial Fibrillation Patients: The COCAF study
Publication
Am Heart J
Publication Date
2004
Authors
Le Heuzey J, Paziaud O, Piot O, Ait S, et al.
Volume & Issue
Volume 147, Issue 1
Pages
121-6
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Atrial fibrillation doubles mortality risk
    Atrial fibrillation is associated with an approximate doubling of mortality risk.  
  • AFib prevalence, 2006
    As much as 1% of the U.S. population is estimated to have atrial fibrillation  
  • Projected AFib incidence, 2050
    If current incidence estimates are applied to Census Bureau projections, by 2050 the number of Americans with atrial fibrillation could exceed 12 million. If increases in incidence continue, that number could…  
  • Lifetime risk of atrial fibrillation
    At age 80, the remaining lifetime risk of atrial fibrillation is around 22%.  
  • Atrial fibrillation as a contributory cause of death
    Around 84% of all deaths with atrial fibrillation as a contributory cause are in individuals age 75 and older.